 Coronary Disease
"Coronary Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Descriptor ID |
D003327
|
| MeSH Number(s) |
C14.280.647.250 C14.907.585.250
|
| Concept/Terms |
Coronary Disease- Coronary Disease
- Coronary Diseases
- Disease, Coronary
- Diseases, Coronary
- Coronary Heart Disease
- Coronary Heart Diseases
- Disease, Coronary Heart
- Diseases, Coronary Heart
- Heart Disease, Coronary
- Heart Diseases, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Disease".
Below are MeSH descriptors whose meaning is more specific than "Coronary Disease".
This graph shows the total number of publications written about "Coronary Disease" by people in this website by year, and whether "Coronary Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 2 | 2 | 4 | | 1993 | 3 | 2 | 5 | | 1994 | 1 | 0 | 1 | | 1995 | 4 | 3 | 7 | | 1996 | 7 | 4 | 11 | | 1997 | 3 | 2 | 5 | | 1998 | 12 | 3 | 15 | | 1999 | 3 | 2 | 5 | | 2000 | 5 | 3 | 8 | | 2001 | 7 | 2 | 9 | | 2002 | 12 | 2 | 14 | | 2003 | 6 | 3 | 9 | | 2004 | 9 | 1 | 10 | | 2005 | 8 | 0 | 8 | | 2006 | 7 | 1 | 8 | | 2007 | 8 | 1 | 9 | | 2008 | 12 | 3 | 15 | | 2009 | 7 | 0 | 7 | | 2010 | 7 | 2 | 9 | | 2011 | 2 | 4 | 6 | | 2012 | 11 | 3 | 14 | | 2013 | 2 | 0 | 2 | | 2014 | 10 | 0 | 10 | | 2015 | 4 | 2 | 6 | | 2016 | 4 | 2 | 6 | | 2017 | 3 | 2 | 5 | | 2018 | 2 | 2 | 4 | | 2019 | 5 | 1 | 6 | | 2020 | 2 | 0 | 2 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Coronary Disease" by people in Profiles.
-
Solomon J, Moss E, Morin JF, Langlois Y, Cecere R, de Varennes B, Lachapelle K, Piazza N, Martucci G, Bendayan M, Piankova P, Hayman V, Ouimet MC, Rudski LG, Afilalo J. The Essential Frailty Toolset in Older Adults Undergoing Coronary Artery Bypass Surgery. J Am Heart Assoc. 2021 08 03; 10(15):e020219.
-
Yang J, Brody EN, Murthy AC, Mehler RE, Weiss SJ, DeLisle RK, Ostroff R, Williams SA, Ganz P. Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease. J Am Heart Assoc. 2020 08 04; 9(15):e016463.
-
Dehmer GJ, Badhwar V, Bermudez EA, Cleveland JC, Cohen MG, D'Agostino RS, Ferguson TB, Hendel RC, Isler ML, Jacobs JP, Jneid H, Katz AS, Maddox TM, Shahian DM. 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization). Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e000059.
-
Schwartz GG, Leiter LA, Ballantyne CM, Barter PJ, Black DM, Kallend D, Laghrissi-Thode F, Leitersdorf E, McMurray JJV, Nicholls SJ, Olsson AG, Preiss D, Shah PK, Tardif JC, Kittelson J. Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Diabetes Care. 2020 05; 43(5):1077-1084.
-
Salahuddin T, Kittelson J, Tardif JC, Shah PK, Olsson AG, Nicholls SJ, Leitersdorf E, Leiter LA, Kallend D, Black DM, Barter PJ, Ballantyne CM, Schwartz GG. Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial. Am Heart J. 2020 03; 221:60-66.
-
Huo X, Krumholz HM, Bai X, Spatz ES, Ding Q, Horak P, Zhao W, Gong Q, Zhang H, Yan X, Sun Y, Liu J, Wu X, Guan W, Wang X, Li J, Li X, Spertus JA, Masoudi FA, Zheng X. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial Circ Cardiovasc Qual Outcomes. 2019 09; 12(9):e005805.
-
Kelley GA, Kelley KS, Stauffer BL. Obesity and cardiovascular outcomes: another look at a meta-analysis of Mendelian randomization studies. J Investig Med. 2020 02; 68(2):357-363.
-
Ward-Caviness CK, de Vries PS, Wiggins KL, Huffman JE, Yanek LR, Bielak LF, Giulianini F, Guo X, Kleber ME, Kacprowski T, Groß S, Petersman A, Davey Smith G, Hartwig FP, Bowden J, Hemani G, Müller-Nuraysid M, Strauch K, Koenig W, Waldenberger M, Meitinger T, Pankratz N, Boerwinkle E, Tang W, Fu YP, Johnson AD, Song C, de Maat MPM, Uitterlinden AG, Franco OH, Brody JA, McKnight B, Chen YI, Psaty BM, Mathias RA, Becker DM, Peyser PA, Smith JA, Bielinski SJ, Ridker PM, Taylor KD, Yao J, Tracy R, Delgado G, Trompet S, Sattar N, Jukema JW, Becker LC, Kardia SLR, Rotter JI, März W, Dörr M, Chasman DI, Dehghan A, O'Donnell CJ, Smith NL, Peters A, Morrison AC. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease. PLoS One. 2019; 14(5):e0216222.
-
Zheng X, Spatz ES, Bai X, Huo X, Ding Q, Horak P, Wu X, Guan W, Chow CK, Yan X, Sun Y, Wang X, Zhang H, Liu J, Li J, Li X, Spertus JA, Masoudi FA, Krumholz HM. Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial Circ Cardiovasc Qual Outcomes. 2019 04; 12(4):e005616.
-
Bancks MP, Ning H, Allen NB, Bertoni AG, Carnethon MR, Correa A, Echouffo-Tcheugui JB, Lange LA, Lloyd-Jones DM, Wilkins JT. Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level. Diabetes Care. 2019 03; 42(3):457-465.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|